Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

Global Listed Private Proshares (PEX)

$27.81 0.22 (0.79%)

20:00 EDT PEX Stock Quote Delayed 30 Minutes

Volume:

Previous Close $27.81

Market Cap 6.26M

PE Ratio -

EPS -

Volume (Avg. Vol.) 3,200

Day's Range 27.46 - 27.81

52-Week Range 17.49 - 36.03

Dividend & Yield 6.76 (24.30%)

PEX Stock Predictions, Articles, and Global Listed Private Proshares News

From InvestorPlace
From the Web

7 Ways to Play Private Equity Without Being a Billionaire

By Will Ashworth, InvestorPlace Contributor Aug 16, 2019

To gain access to these private equity deals, there are some ways a regular Joe can do it. Here are seven options on how to invest in private equity without being a billionaire.

7 Financial ETFs to Buy

By Todd Shriber, InvestorPlace Contributor Mar 18, 2019

While several sectors are outperforming financial services this year, there are some financial ETFs offering impressive returns.

5 Business Development Company (BDC) ETFs to Invest In

By Todd Shriber, InvestorPlace Contributor May 17, 2018

Business development companies are a compelling alternative asset class for income investors, because to be structured as a BDC these companies are required to pay out 90% of their earnings in the form of dividends, as is seen with other income-generating asset classes such as real estate investment trusts (REITs).

Ironwood Pharmaceuticals Inc (IRWD) Q2 2020 Earnings Call Transcript

From The Motley Fool Aug 7, 2020

IRWD earnings call for the period ending June 30, 2020.

Ironwood (IRWD) Q2 Earnings Beat on Solid Linzess Sales

From Zacks Investment Research Aug 7, 2020

Ironwood (IRWD) witnesses strong demand for Linzess in the second quarter. COVID-19 impacts enrollment in clinical studies.

The Exact Trigger that Indicates Volatility in Ironwood Pharmaceuticals Inc

From Capital Market Laboratories Aug 7, 2020

The Trigger That Turned Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Volatility into a Winner.

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates

From Zacks Investment Research Aug 6, 2020

Ironwood (IRWD) delivered earnings and revenue surprises of 100.00% and 6.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Ironwood Pharmaceuticals EPS beats by $0.06, beats on revenue (NASDAQ:IRWD)

From Seeking Alpha Aug 6, 2020

Ironwood Pharmaceuticals (NASDAQ:IRWD): Q2 Non-GAAP EPS of $0.16 beats by $0.06; GAAP EPS of $0.16 beats by $0.08.Revenue of $89.43M (-12.5% Y/Y) beats by $4.05M.Press Release

Pre-earnings Momentum Trade With a Technical Trigger in Ironwood Pharmaceuticals Inc

From Capital Market Laboratories Jul 28, 2020

The Techncial Trigger Driven Option Trade Right Before Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Earnings.